.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

FDA clears commercial optical coherence tomography device

March 1, 2006

The FDA has cleared Heidelberg Engineering GmbH's SL-OCT. According to the company, this is the world's first commercial optical coherence tomography (OCT) device used for cross-sectional anterior segment imaging.

The SL-OCT provides easy-to-use, non-contact cross-sectional scans of the anterior segment. Also possible are measurements of chamber angle, pachymetry, flap thickness, corneal curvature, and comprehensive biometrics, as well as pre- and post-surgical comparisons.